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Matherials and methods 
Animals A Cre-inducible Kir6.2[K185Q,ΔN30] GOF transgenic mouse line under the Rosa26 locus was 
previously generated (9). In this line, CAG-promoter dependent expression of Kir6.2[K185Q,ΔN30] is prevented 
by a loxP-flanked Stop-cassette (Fig. S1A). Cre-mediated recombination excises the Stop-cassette and 
drives Kir6.2[K185Q,ΔN30] expression in a tissue-specific manner along with soluble eGFP via an internal 
ribosomal entry site (IRES) (9). When crossed into appropriate promoter-Cre expressing mice this model 
allows selective induction of transgene expression, thereby modeling tissue-specific expression of KATP-
GOF mutations. 
Behavioral tests  One-hour locomotor activity and sensorimotor battery- Mice were placed in transparent 
polystyrene enclosures (47.6x25.4x20.6cm) and movements were monitored using computerized 
photobeam instrumentation. In ledge and platform tests, mice were placed on an elevated Plexiglas ledge 
(0.75cm wide) or small circular wooden platform (3.0cm diameter) elevated to 30 or 47cm, respectively, 
and the amount of time they remain on the platform was recorded. Screen tests were performed by placing 
mice head-oriented down in a wire mesh grid (16x10cm) elevated 47cm at 60° or 90°. The time taken to 
turn 180° and climb to the top of the wire-mesh was measured. Inverted screen tests began identically to 
screen tests, but the screens were then inverted 180° after ensuring the mouse had a secure grip. The time 
the mouse remain on the screen was measured. In the pole test, mice were oriented head-up with forepaws 
on top of a textured rod (8mmx55cm) and the time the mouse took to turn around and climb-down the pole 
was measured (a maximum score of 120s was assigned if the mouse fell off the pole). For walking initiation, 
mice were placed in the center of a 21x21cm square marked with tape, and the time mice took to leave the 
square was recorded. Each test lasted a maximum of 60s, except pole tests (120s).  
MWM navigation- In cued trials, the escape platform was submerged beneath the water surface, but its 
location was denoted by a red tennis ball atop a rod, which was attached to the escape platform and served 
as a visual cue. To limit spatial learning during cued trials, the location of the platforms was varied across 
trials in the presence of very-few distal spatial cues. In place trials, the platform was hidden beneath the 
water surface and its location was kept constant across all trials, with several salient distal cues being present 
during testing. Mice were placed pseudorandomly into one of the four quadrants of the maze and had to 
learn the location of the submerged platform. 
RNA extraction, cDNA synthesis and qRT-PCR- To address transcriptional levels of KATP channel 
expression, nKATP-GOF and hKATP-GOF brain tissues were subjected to reverse-transcriptase quantitative 
polymerase chain reaction (RT-qPCR). nKATP-GOF, hKATP-GOF, and littermate control mice were 
anesthetized with isofluorane prior to decapitation, then brains dissected into ice-cold PBS. Hippocampi 
were dissected and flash-frozen on liquid nitrogen. Total RNA was extracted from 25-30 mg of 
hippocampal tissue using RNeasy Mini-Kits (Qiagen) with an on-column DNase digestion step to remove 
genomic DNA. RNA concentration was measured using a NanoDrop OneC spectrophotometer (Thermo 
Scientific). 1000ng of RNA was reverse-transcribed in a 20µl final volume using a High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems) alongside a no reverse-transcriptase (No-RT) control. RT-
qPCR- cDNA samples were diluted to a concentration of 5ng/µl with nuclease-free water (Corning). Each 
RT-qPCR reaction consisted of 5µl cDNA (25ng total), 12.5µl 2x PowerSybr Green I Master Mix (Applied 
Biosystems), 0.75µl 10µM forward and reverse primers (300nM), and 6µl nuclease-free water for a total 
reaction volume of 25µl. Reactions were run in triplicate on an Applied Biosystems StepOnePlusTM Real-
Time PCR System. Reaction cycle consisted of an initial denaturation for 10min at 95⁰C, followed by 40 
cycles of 95⁰C for 15s; 60⁰C for 60s. Non-RT and non-DNA controls were included as negative controls in 
all plates. Primers were acquired either from previous publications (10) or the Harvard PrimerBank system, 
with ML32 run as a housekeeping gene (Table S7). Data analysis and relative expression calculation- 
StepOneTM Software (v2.3) was used to acquire RT-qPCR data and calculate cycle threshold (CT) values. 
The delta CT method was used to calculate relative expression levels for comparisons across genotypes, as 
follows:  
KATP-GOF Expression = 𝟐
−(𝑲𝑨𝑻𝑷𝑮𝑶𝑭(𝑪𝑻(𝑻𝒂𝒓𝒈𝒆𝒕 𝑮𝒆𝒏𝒆)−𝑪𝑻(𝑴𝑳𝟑𝟐))−𝑲𝑨𝑻𝑷𝑪𝒐𝒏𝒕𝒓𝒐𝒍(𝑪𝑻(𝑻𝒂𝒓𝒈𝒆𝒕 𝑮𝒆𝒏𝒆)−𝑪𝑻(𝑴𝑳𝟑𝟐))) 
For littermate controls, CT values were averaged, then subtracted from each triplicate value to produce 
average and standard deviation values for relative expression. Differences in gene expression between 
control littermates and KATP-GOF mice were assessed with unpaired Student’s t-tests, with p<0.05 
indicating statistically significant differences in expression. For eGFP expression we reported ∆CT values 
with respect to ML32 since eGFP was not detected in control littermate mice, as expected by a Cre-
dependent construct. All analyses were performed on Microsoft Excel and Graphpad Prism. 
Glucose tolerance tests Intraperitoneal Glucose Tolerance Tests were performed in 12hr fasted mice by 
injection of a bolus of glucose (1.5g/kg body weight). Tail blood was taken before (time 0) and at different 
times (15, 30, 45, 60, 90 and 120min) after glucose challenge and assayed for glucose content using the 
Glucometer Elite XL (Bayer Corp). 
Immunofluorescence To address on-target recombination and transgene expression, anti-eGFP and anti-
Cre immunofluorescence was performed in mouse frozen brain sections. nKATP-GOF, hKATP-GOF and 
littermate controls were perfused transcardially with Tyrode’s-buffered saline (TBS) and fixative. TBS 
consisted of 0.85% NaCl and 25mM TRIZMA Base (Sigma), adjusted to pH=7.4 with HCl. Fixative 
consisted of 4% paraformaldehyde (PFA) and 0.1M monobasic monohydrate NaH2PO4, adjusted to pH=7.4 
with NaOH. Brains were removed and placed for 4hrs in fixative before transfer to a sucrose gradient 
consisting of one overnight calibration in 15% sucrose in phosphate-buffered saline (PBS) followed by one 
overnight calibration in 30% sucrose in PBS. Whole brains were then frozen in blocks of Optimal Cutting 
Temperature (OCT) embedding medium over liquid nitrogen, sectioned sagittally or coronally at 7-10µm 
and plated onto Superfrost microscope slides for subsequent imaging. Cryosections were co-stained with 
anti-GFP (Abcam, Chk, ab13970, 1:500) and anti-Cre (Novagene; Rb, 69050, 1:1000) primary antibodies 
to detect KATP transgene (since eGFP was co-expressed with mutant KATP) and Cre expression. TruBlk 
quenching dye (1:20) was used to reduce background autofluorescence, and a secondary antibody 
concentration of 1:500 was applied. 
Long-term potentiation  
Hippocampal slice preparation- Sucrose-based slicing solutions were prepared as 87mM NaCl, 2.5mM 
KCl, 1.25mM anhydrous monobasic NaH2PO4, 25mM D-glucose, 75mM sucrose, and 25mM NaHCO3. 
After 15min bubbling at room-temperature (RT) with 95% carbogen, 0.5mM CaCl2 and 3mM MgCl2 were 
added. Choline chloride-based solution was prepared as 92mM choline chloride, 2.5mM KCl, 1.2mM 
NaH2PO4, 25mM D-glucose, 5mM sodium ascorbate, 2mM thiourea, 3mM sodium pyruvate, 20mM 
HEPES, 30mM NaHCO3). Recording aCSF consisted of 125mM NaCl, 2.5mM KCl, 1.25mM anhydrous-
monobasic NaH2PO4, 3mM myo-inositol, 10mM D-glucose, 2mM sodium-pyruvate, and 25mM NaHCO3. 
After 15min bubbling at RT with 95% carbogen, 2mM CaCl2 and 1mM MgCl2 were added. Slices were 
transferred to a choline chloride-based solution and allowed to recover at 32C in aCSF/95% carbogen for 
30min before transfer to recording aCSF solutions at 30C. Slices were incubated at 30C in recording aCSF 
before transfer to a nylon-mesh recording chamber at 30C.  
Measurement of fEPSP (electrophysiology)- Stimulating electrodes were placed at the interface of CA2 and 
CA1 in stratum radiatum, at the level of Schaffer Collateral fibers. Recording electrodes were placed 
distally into CA1 in both stratum radiatum and stratum pyramidale to capture synaptic events generated by 
action potentials traveling down the Schaffer collaterals and population spikes generated by CA1 pyramidal 
neurons, respectively. Internal solutions for recording pipettes consisted of aCSF. Recordings were 
performed on a MultiClamp 700B amplifier, digitized using a Digidata 1550 converter, and sampled at 
20kHz at a filter bandwidth of 5kHz. The recording electrodes were borosilicate glass pipettes of ~one 
micron, granting an access resistance of 4-8MΩ. LTP were performed in current clamp-mode (Grass 
Instrument Co./Model-P511K pre-amplifier, Warner Instruments/Model-IE-210 electrometer, Digidata-
1322A analog-to-digital converter) at 30C.  
Whole-cell Patch Clamp Electrophysiology in Dissociated Hippocampal Neurons- Hippocampal tissue 
cultures (single-cell suspension onto collagen-coated tissue-culture plates) were incubated at least seven 
and up to fourteen days prior to patch-clamp recording. Low-potassium solutions (Na1, Na2) consisted of 
2mM CaCl2, 1mM MgCl2, 10mM glucose, 135mM NaCl, 5mM KCl, 10mM HEPES, pH 7.2 w/ NaOH. 
Borosilicate pipettes were pulled to an access resistance between 4-8MΩ. Cells were first bathed in high 
sodium bath (identical to low-potassium solution) prior to local perfusion with experimental solutions, 
which were always applied in the following order: Low potassium 1 (Na1), high potassium 1 (K1), 
diazoxide (Dz), tolbutamide (Tol), high potassium 2 (K2), low potassium 2 (Na2). Low-potassium solutions 
(Na1, Na2) and the sodium bath were identical. High-potassium solutions (K1, K2) substituted 125 mM 
KCl and 5 mM NaCl for the concentrations in standard bath (pH with KOH). Diazoxide (Dz) and 
tolbutamide (Tol) solutions were identical to high potassium solutions with the addition of 300µM 
diazoxide and 500µM tolbutamide, respectively. All solutions also contained 1µM NBQX, 25µM APV, 
10µM bicuculline, and 250nM TTX to isolate KATP-mediated currents (44). Internal solution consisted of 
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Kir6.2  SUR1  
Fig S1. Scheme of breeding strategy, glucose tolerance and KATP gene expression (A) schematic 
representation of Cre-dependent KATP-GOF mutation. The ROSA26 locus contains the loxP-flanked stop 
cassette, a pore-forming GOF mutation (Kir6.2[K185Q,∆N30]), and a GFP reporter under control of IRES (20). 
ROSA26-KATP-GOF mice were crossed with synapsin-Cre (Syn-Cre) (B), dopamine-receptor-D3-Cre 
(Drd3-Cre) (C) or tamoxifen-inducible pancreatic-homeobox1-Cre (Pdx-CreERTM (D) mice to generate 
pan-neuronal nKATP-GOF, hippocampal specific hKATP-GOF or pancreatic β-cell specific βKATP-GOF mice, 
respectively, alongside Cre-containing, ROSA26-containing, and wild-type littermates. Glucose tolerance 
tests in (E) nKATP-GOF mice (red, n=7) and littermate controls (grey, n=7), (F) hKATP-GOF mice (blue, 
n=11) and littermate controls (grey, n=12), and (G) βKATP-GOF mice (purple, n=8) and littermate controls 
(grey, n=8). All tests shown in this figure were acquired from the same cohort. (H) Hippocampal gene 
expression of Kir6.2 and SUR1 relative to ML32 (left) and ∆CT for eGFP (right) in nKATP-GOF mice (red, 
n=3) and littermate controls (grey, n=3). (I) Hippocampal gene expression of Kir6.2 and SUR1 (left) and 
∆CT for eGFP (right) in hKATP-GOF mice (blue, n=3) and littermate controls (grey, n=3). *p<0.05 and 





Fig. S2. Immunostaining of frozen brain sections in nKATP-GOF and hKATP-GOF mice. Anti-Cre (red) 
and anti-GFP (green) immunostaining in frozen sections of (A) nKATP-GOF and (B) hKATP-GOF. Control 
mice were used as negative control (C). DAPI nuclear staining in (blue).  
Fig. S3.  Sex effects in time on ledge and auditory cue tests for nKATP-GOF male and female mice. (A)  
Sensorimotor Battery test: time on ledge, (B) fear conditioning test: freezing during auditory cue. nKATP-
GOF mice (red, n=7 males and n=7 females) and littermate control mice (gray, n=6 males and n=7 females). 
*p<0.05, **p<0.01, ***p<0.01****p<0.0001. All data in this figure were acquired from the same cohort. 
 
Fig. S4.  Baseline fEPSP slopes before LTP induction (A) Left: fEPSP slopes during baseline period in 
nKATP-GOF (red, n=7, 5 mice) and control littermates (grey, n=10, 6 mice); Right: average of baseline 
fEPSP slopes in left panel (B) Left: fEPSP slopes during baseline period in hKATP-GOF (blue, n=8, 3 mice) 
and control littermates (grey, n=12, 8 mice); Right: average of baseline fEPSP slopes in left panel. Non-
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Fig. S5. Diabetic βKATP-GOF mice did not show most neurological features of DEND. Locomotor 
activity: (A)  total ambulations, (B) vertical rears, (C) distance traveled in the periphery, (D) center entries 
and (E) time resting in βKATP-GOF mice (purple, n=12) and littermate controls (white, n=10). Sensorimotor 
battery: (F,G) climb to the top of the 60º and 90º inclined screen, (H) time on the ledge, (I) time to climb-
down pole and (J) time on inverted screen. MWM cue trials:  (K) escape path length, (L) latency. MWM 
place trials:  (M) escape path length, (N) latency. MWM probe trials:  (O) platform crossing and (P) time 
in target quadrant and spatial bias. Fear-conditioning: (Q) tone-shock baseline-training, (R) contextual fear 
and (S) auditory cue tests. *p<0.05, **p<0.01, ****p<0.0001. All data shown in this figure were acquired 





Table S1. Means and ANOVA effects for locomotor activity assays, sensorimotor battery, and 
rotarod assays for nKATP-GOF and control mice 
 
Table S2. Means and ANOVA effects for Morris Water Maze and fear conditioning assays in nKATP-
GOF and control mice 
 
Table S3. Means and ANOVA effects for locomotor activity assays, sensorimotor battery, and 
rotarod assays for hKATP-GOF and control mice 
 
Table S4. Means and ANOVA effects for Morris Water Maze and fear conditioning assays in 
hKATP-GOF and control mice 
 
Table S5. Means and ANOVA effects for locomotor activity assays, sensorimotor battery, Morris 
Water Maze, and fear conditioning assays in nKATP-Glib-GOF and control mice 
 
Table S6. Means and ANOVA effects for locomotor activity assays, sensorimotor battery, Morris 
Water Maze, and fear conditioning assays in βKATP-GOF and control mice.  
Short name Primer Sequence (5’-3’) 
Kir6.2 fwd CGG GCG CAT GGT GAC AGA GG 
rev CGA TGG GCC TGG GCC GTT TT 
SUR1 fwd TGA GCA TTG GAA GAC CCT CAT 
rev CAG CAC CGA AGA TAA GTT GTC A 
GFP fwd AAG GGC ATC GAC TTC AAG G 
rev TGC TTG TCG GCC ATG ATA TAG 
ML32 fwd TTC CTG GTC CAC AAT GTC AA 
rev GGC TTT TCG GTT CTT AGA GGA 
 
Table S7. Primers for RT-qPCR 
 
